Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. VMD
VMD logo

VMD Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
9.215
Open
9.210
VWAP
8.85
Vol
703.70K
Mkt Cap
336.23M
Low
8.620
Amount
6.23M
EV/EBITDA(TTM)
6.88
Total Shares
38.60M
EV
337.08M
EV/OCF(TTM)
5.06
P/S(TTM)
1.24
Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services.
Show More

Events Timeline

(ET)
2026-03-04
16:50:00
Viemed Healthcare Authorizes Share Repurchase Program Through March 2027
select
2025-07-02 (ET)
2025-07-02
08:43:56
Viemed Healthcare completes acquisition of Lehan's Medical Equipment
select
2025-06-09 (ET)
2025-06-09
08:18:09
Viemed Healthcare board authorizes share repurchase program up to 5%
select
2025-05-06 (ET)
2025-05-06
08:32:47
Viemed entered into definitive agreement to acquire Lehan's Medical Equipment
select
2025-03-10 (ET)
2025-03-10
17:02:06
Viemed Healthcare sees FY25 revenue $254M-$265M, consensus $251.43M
select
2025-03-10
17:01:21
Viemed Healthcare reports Q4 EPS 10c vs 9c last year
select

News

NASDAQ.COM
2.0
03-05NASDAQ.COM
Viemed (VMD) Q4 2025 Earnings Call Transcript
seekingalpha
9.5
03-05seekingalpha
Viemed Healthcare Q4 Earnings Beat Expectations
  • Earnings Highlights: Viemed Healthcare reported Q4 GAAP EPS of $0.14, beating expectations by $0.05, although revenue of $76.2 million, up 25.5% year-over-year, missed by $1.15 million, indicating challenges in balancing growth and profitability.
  • Adjusted EBITDA Growth: For the year ending December 31, 2025, adjusted EBITDA reached $18.2 million, with a record $61.4 million for the full year, demonstrating the company's ability to maintain strong profitability amid ongoing growth, which bolsters investor confidence.
  • Significant Free Cash Flow Increase: The free cash flow for 2025 totaled $28.1 million, a substantial increase from $11.6 million in 2024, reflecting improvements in operational efficiency and cash management, which will support future investments and shareholder returns.
  • 2026 Financial Guidance: The company expects net revenue for 2026 to be in the range of $310 million to $320 million, below the market consensus of $328.73 million, with adjusted EBITDA projected between $65 million and $69 million, indicating a cautiously optimistic outlook for future growth.
seekingalpha
8.0
03-04seekingalpha
Viemed Healthcare Authorizes Share Repurchase Program
  • Repurchase Program Initiation: Viemed Healthcare's board approved a share repurchase program on Wednesday, allowing for the buyback of up to 1,930,131 common shares, which represents approximately 5% of its issued shares as of March 4, 2026.
  • Flexible Repurchase Methods: The company plans to execute repurchases through open market or block purchases, adhering to applicable securities laws, including Rule 10b-18 under the Securities Exchange Act of 1934, ensuring compliance and transparency.
  • Daily Purchase Limitations: Daily repurchases will be capped at 25% of the average daily trading volume over the preceding four weeks, which aims to mitigate market volatility and protect shareholder interests during the buyback period.
  • Share Cancellation Policy: Shares repurchased under this program will be canceled, and while the company has indicated that there is no assurance regarding the number of shares to be repurchased, the ability to discontinue purchases at any time reflects a cautious and flexible approach to capital management.
seekingalpha
9.5
03-04seekingalpha
Viemed Healthcare to Announce Q4 Earnings on March 5
  • Earnings Announcement: Viemed Healthcare is set to release its Q4 earnings on March 5 before market open, with consensus EPS estimates at $0.13, reflecting a 30% year-over-year increase.
  • Revenue Expectations: The company anticipates Q4 revenue of $77.7 million, representing a 28% year-over-year growth, which underscores its robust performance in the small-cap healthcare sector amid ongoing market demand.
  • Investor Confidence: Viemed Healthcare's quant rating indicates strong investor optimism regarding its valuation, particularly in light of buoyant cash flow, which further bolsters market confidence in its future growth prospects.
  • Technical Analysis: Small-cap healthcare stocks are surging, with Viemed Healthcare's stock price surpassing the 200-day moving average, indicating strong momentum in the market and potential investment opportunities.
Newsfilter
9.5
02-24Newsfilter
Viemed to Host Year End 2025 Earnings Call on March 5
  • Earnings Call Announcement: Viemed Healthcare will host its Year End 2025 earnings conference call on March 5, 2026, at 11:00 a.m. ET, aimed at providing the latest financial performance updates to investors and stakeholders.
  • Participation Details: Interested parties can join the call by dialing 877-407-6176 (US Toll-Free) or +1 201-689-8451 (International), ensuring global investors have convenient access to the company's updates.
  • Webcast Replay Availability: Following the live call, a replay will be accessible in the Investor Relations section of the company's website, enhancing information transparency and investor engagement.
  • Company Overview: Viemed Healthcare focuses on home medical equipment and post-acute healthcare services in the U.S., emphasizing efficient chronic disease management through high-quality home care and technology-enabled support, showcasing its strategic positioning in the healthcare sector.
seekingalpha
4.5
02-11seekingalpha
Small-Cap Stocks Surge, Led by Healthcare Sector
  • Small-Cap Outperformance: Year-to-date in 2026, the iShares Core S&P Small-Cap ETF (IJR) has surged 10.9%, significantly outperforming the SPDR S&P 500 ETF Trust (SPY) which only rose 1.4%, indicating a potential shift in investor sentiment towards small-cap stocks after years of underperformance.
  • Healthcare Stocks Leading: Viemed Healthcare (VMD) tops the list with a last price percentage of 19.89% versus the 200-day simple moving average (200DSMA), showcasing its strong market performance and likely attracting investor interest and capital inflow.
  • Strong Performers in Healthcare: Following VMD, MannKind (MNKD) and Verano Holdings (VRNO) exhibit impressive figures of 18.85% and 17.30% respectively against the 200DSMA, highlighting their competitive positioning and growth potential in the healthcare sector.
  • Healthcare Sector Dynamics: Notably, 22 out of 23 healthcare firms reported earnings per share (EPS) beats this week, reflecting robust performance in the healthcare industry, which may bolster investor confidence and drive further gains in healthcare stocks.

Valuation Metrics

The current forward P/E ratio for Viemed Healthcare Inc (VMD.O) is 12.69, compared to its 5-year average forward P/E of 25.29. For a more detailed relative valuation and DCF analysis to assess Viemed Healthcare Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
25.29
Current PE
12.69
Overvalued PE
32.78
Undervalued PE
17.80

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
6.47
Current EV/EBITDA
4.15
Overvalued EV/EBITDA
8.47
Undervalued EV/EBITDA
4.48

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.51
Current PS
0.88
Overvalued PS
2.02
Undervalued PS
1.01

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

best swing trades at or near $10
Intellectia · 27 candidates
Price: $8.00 - $12.00Rsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Month Price Change Pct: $5.00 - $25.00One Week Predict Return: 0.0% - 100.0%Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ANGO logo
ANGO
AngioDynamics Inc
462.46M
HLX logo
HLX
Helix Energy Solutions Group Inc
1.31B
HTLD logo
HTLD
Heartland Express Inc
910.75M
VMD logo
VMD
Viemed Healthcare Inc
313.27M
LNKB logo
LNKB
LINKBANCORP Inc
346.49M
SENS logo
SENS
Senseonics Holdings Inc
333.41M
what trades can I do within my budget
Intellectia · 43 candidates
Region: USPrice: $5.00 - $50.00Rsi Category: moderate, overboughtPrice Change Pct: $2.00 - $10.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SIRI logo
SIRI
Sirius XM Holdings Inc
7.69B
BYRN logo
BYRN
Byrna Technologies Inc
281.11M
RMR logo
RMR
RMR Group Inc
533.45M
ASX logo
ASX
ASE Technology Holding Co Ltd
43.15B
ORN logo
ORN
Orion Group Holdings Inc
545.05M
MCFT logo
MCFT
Mastercraft Boat Holdings Inc
395.64M

Whales Holding VMD

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Viemed Healthcare Inc (VMD) stock price today?

The current price of VMD is 8.71 USD — it has decreased -5.53

What is Viemed Healthcare Inc (VMD)'s business?

Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services.

What is the price predicton of VMD Stock?

Wall Street analysts forecast VMD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for VMD is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Viemed Healthcare Inc (VMD)'s revenue for the last quarter?

Viemed Healthcare Inc revenue for the last quarter amounts to 76.18M USD, increased 25.51

What is Viemed Healthcare Inc (VMD)'s earnings per share (EPS) for the last quarter?

Viemed Healthcare Inc. EPS for the last quarter amounts to 0.14 USD, increased 40.00

How many employees does Viemed Healthcare Inc (VMD). have?

Viemed Healthcare Inc (VMD) has 1382 emplpoyees as of March 23 2026.

What is Viemed Healthcare Inc (VMD) market cap?

Today VMD has the market capitalization of 336.23M USD.